Tag Archives: Ben Fidler

Alzeca Receives $11M for Early Alzheimer’s Detection Technology

Houston—Alzeca, which is developing an imaging agent to help doctors detect Alzheimer’s disease at its earliest stages, announced Thursday it has raised $11 million in a Series A round of funding. The Houston-based company has developed an imaging agent that it says can, when used with an MRI, detect the presence of abnormal brain proteins […]

Posted in Indiana blog main, National blog main, National top stories, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Alzeca Receives $11M for Early Alzheimer’s Detection Technology

FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis

[Updated 7/2/15, 2:55 p.m. See below.] The long-expected approval of Vertex Pharmaceuticals’ new combination drug for cystic fibrosis is finally here. The FDA approved the therapy regimen in a letter it sent to the Boston-based company Thursday. The drug’s approval was all but certain, and paves the way for potential billions of dollars in future sales. […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis

SQZ Biotech Shifts to Therapy Development with $5M Series A

Scientists lucky enough to develop a breakthrough technology often still face the difficult task of commercializing the product. Do they license the technology to researchers? Do they develop it themselves, or maybe instead find a bigger, more experienced partner? SQZ Biotech finds itself today in such a time of transition. The Boston startup, founded through […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on SQZ Biotech Shifts to Therapy Development with $5M Series A

West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon

This week, we’ll take our roundup on a West Coast roadtrip from south to north. First, down San Diego way, the news the past seven days was mostly financial, led by Tracon Pharmceuticals’ IPO. In San Francisco, Genentech had breakthrough news, while KaloBios had more bad news. And in Seattle, bankrupt Dendreon found a potential […]

Posted in National blog main, San Diego, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon

Guardant Grabs $50M to Expand Cancer Blood Test

Guardant Health has received a $50 million Series C funding round to make its blood test for cancer more readily available. The test, called Guardant360, analyzes the genetic traits of tumor cell DNA, which can help physicians predict what therapies might be most effective at treating a patient. As Xconomy’s Bernadette Tansey wrote after she […]

Posted in National blog main, National top stories, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Guardant Grabs $50M to Expand Cancer Blood Test

Q2 In Review: Fire, Fundings, Floating Wind, Biotech Ups and Downs

Happy Fourth of July, everyone. Here’s a review of some notable Xconomy Seattle stories from the second quarter. Enjoy the holiday weekend! Ahead of Amazon’s smartphone announcement, Curt Woodward looked at why the company wanted to build one in the first place. And here’s Woodward’s take on the Fire phone as another way the e-commerce […]

Posted in National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged , , , , , , , | Comments Off on Q2 In Review: Fire, Fundings, Floating Wind, Biotech Ups and Downs

Farewell, Xconomy Readers. I’m Going to Climb a New Mountain

This is my last week on the job at Xconomy. After almost six years, I’m moving on. I’m going to finish writing a biography of Leroy Hood, the pioneer of high-speed DNA sequencing and genomic-based personalized medicine. And then I’ll see what’s next. When I first joined Xconomy, it had been founded 10 months earlier […]

Posted in Boston blog main, Boulder/Denver blog main, Detroit blog main, National, National blog main, New York blog main, San Diego blog main, San Francisco blog main, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged , , , , , , , | 21 Comments

Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker

Celgene is best known for taking a notoriously dangerous compound, thalidomide, and turning a derivative into a hugely successful cancer drug. But what fewer people may realize is that it is fast building the biotech industry’s best network of partnerships with innovators. This feels odd to say, even though Celgene (NASDAQ: CELG) has been a […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, National, National blog main, National top stories, New York blog main, New York top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

NY Editor’s Picks: Xconomy Stories That Got This City Talking in Q2

With Xconomy’s mission of highlighting how innovation can drive exponential growth in the economy, it’s important to look back at stories that speak to the character of the cities we cover. My esteemed colleagues in Boston, San Francisco, Boulder/Denver, and Seattle have already shared some of their favorites from the second quarter of this year. […]

Posted in National blog main, New York, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on NY Editor’s Picks: Xconomy Stories That Got This City Talking in Q2

Meet Ben Fidler, Xconomy’s New East Coast Biotech Editor

Today is the IRS tax filing deadline, which is a bummer for some people. But it’s a very exciting day here at Xconomy. It’s my pleasure to announce that today is the first full day on the job for Ben Fidler, our new East Coast Biotech Editor. Ben joins us after spending the last nine […]

Posted in Boston blog main, National blog main, National top stories, New York, New York blog main, New York top stories | Tagged , , , , , , , , , , , , | Comments Off on Meet Ben Fidler, Xconomy’s New East Coast Biotech Editor